Xilio Therapeutics, Inc. (XLO) Reports 26% Response in Colon Cancer Drug Trial
Xilio Therapeutics, Inc.
Xilio Therapeutics Inc. (XLO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 592,300 | $5,674,234 | 0.11% | |
| 2. | Stonepine Capital Timothy P. Lynch | 225,994 | $2,165,023 | +253% | 1.22% |
| 3. | Sio Capital Michael Castor | 152,464 | $1,460,605 | 0.24% | |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 111,541 | $1,068,563 | 0% | |
| 5. | Renaissance Technologies Jim Simons | 64,153 | $614,586 | +30% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.79 | 5,000 | $43,950.00 | 10,000 | 2026-03-26 | Filing | |
| $0.69 | 25,000 | $17,215.00 | 70,000 | 2025-06-17 | Filing | |
| $0.69 | 45,000 | $30,870.00 | 45,000 | 2025-06-16 | Filing | |
| $0.68 | 36,289 | $24,680.15 | 281,172 | 2025-06-16 | Filing | |
| $1.04 | 1,759,978 | $1,830,377.12 | 9,105,451 | 2024-12-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.64 | 1,826 | $1,174.48 | 6,371 | 2026-01-02 | Filing | |
| $0.64 | 7,030 | $4,521.70 | 24,766 | 2026-01-02 | Filing | |
| $0.98 | 6,954 | $6,840.65 | 12,421 | 2025-01-02 | Filing | |
| $0.98 | 1,803 | $1,773.61 | 3,197 | 2025-01-02 | Filing | |
| $0.64 | 267 | $170.88 | 734,546 | 2024-02-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 664,021 | $6,361,322 | 0.38% | |
| 2. | 650,389 | $6,230,727 | 0.38% | |
| 3. | 422,505 | $4,047,598 | 0.09% | |
| 4. | 178,517 | $1,710,193 | 0% | |
| 5. | 105,982 | $1,015,308 | 0.19% |
News See All
Hedge Fund Resource Center